Kimioterapiaren ondorengo anemiaren eta sukar-neutropeniaren maneiua
PDF

Gako-hitzak

anemia
ukar-neutropenia
kimioterapia

Aipuak nola egin

Landa Alberdi, J., Leunda Eizmendi, L., Ercilla Liceaga, M., Umerez Igartua, M., Lizardi Mutuberria, A., Garcia de Andoin Barandiaran, M. J., Urretavizcaya Anton, M., Beristain Aramendi, I., & Ulacia Epelde, L. (2024). Kimioterapiaren ondorengo anemiaren eta sukar-neutropeniaren maneiua. Osagaiz: Osasun-Zientzien Aldizkaria, 8(1), 101–106. Berreskuratua -(e)tik https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/567

Laburpena

Gaixo onkologikoen artean, ohiko konplikazioak dira anemia eta sukar-neutropenia, batez ere kimioterapia jasotzen dutenen artean. Eragin desiragaitz horiek garaiz diagnostikatu eta tratatzea beharrezkoa da, gaixoen biziraupenean eta bizi-kalitatean eragin negatiboa baitute.

 

 

PDF

Erreferentziak

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J, on behalf of the ESMO Guidelines Committee. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29 (Supplement 4): iv96–iv110.

National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology; Hematopoietic growth factors. v.2.2020, 2020.

Douglas Rizzo J, Browers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S. American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the use or epoetin and darbepoetin in adult patients with cancer. Blood. 2010; 116: 4045-4059.

Flores Balcázar C, Rosales Pérez S, Galván Salazar G, López Navarro O. Anemia inducida por quimioterapia en pacientes oncológicos: papel de los agentes eritropoyéticos. iMedPub Journals. 2015; 11 doi: 10.3823/1217.

WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1) [Kontsulta 2023/04/05]. Eskuragarri:

https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf

Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrsdt J, on behalf of the ESMO Guidelines Committee. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines, Annals of Oncology, Volume 27, Issue suppl_5, 1 September 2016, Pages v111–v118, https://doi.org/10.1093/annonc/mdw325

National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology; Prevention and treatment of cancer-related infections. v.1.2020, 2019.

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO, on behalf of the American Society of Clinical Oncology. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015; 33: 3199-3212.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018; 36: 1443-1453.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR. Antimicrobial Prophylaxis for Adult Patients With Cancer Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018; 36: 3043-3054.

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Peter Donelly J, Kearny N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, on behalf of the European Organisation for Research and Treatment of Cancer. 2010 Update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011; 47: 8-32.

Comité de Política Antibiótica- Hospital Universitario Donostia. Guía de tratamiento empírico de las enfermedades infecciosas. 2ª Edición. Donostia: Comunicación OSI Donostialdea; 2017.

Mensa J. et al. Guía de terapéutica antimicrobiana. Edición del 2022. Barcelona: Antares; 2022.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2024 June Landa Alberdi, Larraitz Leunda Eizmendi, Miren Ercilla Liceaga, Maitane Umerez Igartua, Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Mikel Urretavizcaya Anton, Idoia Beristain Aramendi, Leire Ulacia Epelde